Teruhito Takakuwa

Shinsaibashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Development and implementation of a regional medical collaboration platform for hematological malignancies

Development and implementation of a regional medical collaboration platform for hematological malignancies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Teclistamab for multiple pulmonary lesions in extramedullary myeloma: first successful case and review of the literature.

Teclistamab for multiple pulmonary lesions in extramedullary myeloma: first successful case and review of the literature.

Journal: Annals of hematology

Published: March 07, 2026

Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective study.

Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective study.

Journal: International journal of hematology

Published: October 23, 2025

Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel.

Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel.

Journal: Japanese journal of clinical oncology

Published: May 27, 2025

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 29, 2025

Usefulness of web-based application for health surveys before and after peripheral blood stem cell harvest from healthy donors

Usefulness of web-based application for health surveys before and after peripheral blood stem cell harvest from healthy donors

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 02, 2024

The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients.

The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients.

Journal: Annals of hematology

Published: May 30, 2024

Dynamic Relapse Prediction by Peripheral Blood WT1mRNA after Allogeneic Hematopoietic Cell Transplantation for Myeloid Neoplasms.

Dynamic Relapse Prediction by Peripheral Blood WT1mRNA after Allogeneic Hematopoietic Cell Transplantation for Myeloid Neoplasms.

Journal: Transplantation and cellular therapy

Published: April 21, 2024

Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation.

Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation.

Journal: Transplant immunology

Published: April 03, 2024

Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation.

Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation.

Journal: European journal of haematology

Published: March 20, 2024

T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity "graft-versus-leukemia effects".

T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity "graft-versus-leukemia effects".

Journal: Blood cancer journal

Published: February 15, 2024

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Journal: Cancer immunology, immunotherapy : CII

Published: February 14, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026